Dec 03, 2020
VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors
Nov 19, 2020
VolitionRx Limited to Present COVID-19 Data at MEDICA 2020
Nov 10, 2020
Volition Veterinary Presents Expert Report Ahead of First Product Launch
Sep 29, 2020
VolitionRx Limited Announces Virtual Capital Markets Day 2020
May 19, 2020
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
Feb 20, 2020
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
Feb 18, 2020
Volition Unveils Its Epigenetic Toolbox
Feb 18, 2020
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update
Jan 10, 2020
VolitionRx Completes Acquisition of Octamer GmbH
Nov 12, 2019
VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update
Oct 25, 2019
Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC
Oct 18, 2019
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas
Aug 12, 2019
VolitionRx Limited Announces Second Quarter 2019 Financial Results and Business Update
Aug 08, 2019
Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer
Jul 24, 2019
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
Jul 10, 2019
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
Apr 09, 2019
VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report
Apr 09, 2019
VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics
Mar 25, 2019
VolitionRx Limited to Present at Conferences in March & April 2019
Mar 15, 2019
VolitionRx Limited to Present at Conferences in the U.S. Next Week